Systematic single cell analysis of migration and morphological changes of human neutrophils over stimulus concentration gradients

Journal of Immunological Methods

Volumn 404, Issue 1, 2014, Pages 59-70

  Yamauchi, Akira ^a   Degawa Yamauchi, Mikako ^b   Kuribayashi, Futoshi ^a   Kanegasaki, Shiro ^c   Tsuchiya, Tomoko ^c  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b Phoenix Medical Clinic   (Japan)

^c Yeungnam University   (South Korea)

Author keywords

Chemoattractants; Chemotaxis; Imaging; Lamellipodia; Polarity; TAXIScan

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; LEUKOTRIENE B4; THROMBOCYTE ACTIVATING FACTOR;

ANALYTICAL EQUIPMENT; ARTICLE; CELL MIGRATION; CELL STIMULATION; CELL STRUCTURE; CELL SUSPENSION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE CELL ANALYSIS; TAXISCAN;

CHEMOATTRACTANTS; CHEMOTAXIS; IMAGING; LAMELLIPODIA; POLARITY; TAXISCAN;

ADULT; CHEMOTAXIS, LEUKOCYTE; FEMALE; HUMANS; INTERLEUKIN-8; LEUKOTRIENE B4; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PLATELET ACTIVATING FACTOR; PRIMARY CELL CULTURE; SINGLE-CELL ANALYSIS;

EID: 84896706583     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.12.005     Document Type: Article

References (38)

1. Ambruso D.R., Knall C., Abell A.N., Panepinto J., Kurkchubasche A., Thurman G., Gonzalez-Aller C., Hiester A., deBoer M., Harbeck R.J., Oyer R., Johnson G.L., Roos D. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:4654.
2. Bäck M., Dahlén S.E., Drazen J.M., Evans J.F., Serhan C.N., Shimizu T., Yokomizo T., Rovati G.E. International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions. Pharmacol. Rev. 2011, 63:539.
3. Bagorda A., Mihaylov V.A., Parent C.A. Chemotaxis: moving forward and holding on to the past. Thromb. Haemost. 2006, 95:12.
4. Braquet P., Touqui L., Shen T.Y., Vargaftig B.B. Perspectives in platelet-activating factor research. Pharmacol. Rev. 1987, 39:97.
5. Carbo C., Duerschmied D., Goerge T., Hattori H., Sakai J., Cifuni S.M., White G.C., Chrzanowska-Wodnicka M., Luo H.R., Wagner D.D. Integrin-independent role of CalDAG-GEFI in neutrophil chemotaxis. J. Leukoc. Biol. 2010, 88:313.
6. Dormann D., Weijer C.J. Imaging of cell migration. EMBO J. 2006, 25:3480.
7. Ford-Hutchinson A.W. Leukotriene B4 and neutrophil function: a review. J. R. Soc. Med. 1981, 74:831.
8. Ford-Hutchinson A.W., Bray M.A., Doig M.V., Shipley M.E., Smith M.J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980, 286:264.
9. Heit B., Tavener S., Raharjo E., Kubes P. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol. 2002, 159:91.
10. Honda Z., Ishii S., Shimizu T. Platelet-activating factor receptor. J. Biochem. 2002, 131:773.
11. Ishii M., Egen J.G., Klauschen F., Meier-Schellersheim M., Saeki Y., Vacher J., Proia R.L., Germain R.N. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 2009, 458:524.
12. Kanegasaki S., Nomura Y., Nitta N., Akiyama S., Tamatani T., Goshoh Y., Yoshida T., Sato T., Kikuchi Y. A novel optical assay system for the quantitative measurement of chemotaxis. J. Immunol. Methods 2003, 282:1.
13. Kitayama J., Carr M.W., Roth S.J., Buccola J., Springer T.A. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils. J. Immunol. 1997, 158:2340.
14. Kubota T., Arita M., Isobe Y., Iwamoto R., Goto T., Yoshioka T., Urabe D., Inoue M., Arai H. Eicosapentaenoic acid is converted via ω-3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid. FASEB J. 2014, (in press). 10.1096/fj.13-236224.
15. Matsushima K., Morishita K., Yoshimura T., Lavu S., Kobayashi Y., Lew W., Appella E., Kung H.F., Leonard E.J., Oppenheim J.J. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med. 1988, 167:1883.
16. Montgomery L.D., Williams B.A. Effect of ambient temperature on the thermal profile of the human forearm, hand, and fingers. Ann. Biomed. Eng. 1976, 4:209.
17. M'Rabet L., Coffer P.J., Wolthuis R.M., Zwartkruis F., Koenderman L., Bos J.L. Differential fMet-Leu-Phe- and platelet-activating factor-induced signaling toward Ral activation in primary human neutrophils. J. Biol. Chem. 1999, 274:21847.
18. Murphy P.M., Baggiolini M., Charo I.F., Hébert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., Power C.A. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000, 52:145.
19. Nick J.A., Avdi N.J., Young S.K., Knall C., Gerwins P., Johnson G.L., Worthen G.S. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Invest. 1997, 99:975.
20. Nishikimi A., Fukuhara H., Su W., Hongu T., Takasuga S., Mihara H., Cao Q., Sanematsu F., Kanai M., Hasegawa H., Tanaka Y., Shibasaki M., Kanaho Y., Sasaki T., Frohman M.A., Fukui Y. Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis. Science 2009, 324:384.
21. Nishio M., Watanabe K., Sasaki J., Taya C., Takasuga S., Iizuka R., Balla T., Yamazaki M., Watanabe H., Itoh R., Kuroda S., Horie Y., Förster I., Mak T.W., Yonekawa H., Penninger J.M., Kanaho Y., Suzuki A., Sasaki T. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1. Nat. Cell Biol. 2007, 9:36.
22. Nitta N., Tsuchiya T., Yamauchi A., Tamatani T., Kanegasaki S. Quantitative analysis of eosinophil chemotaxis tracked using a novel optical device - TAXIScan. J. Immunol. Methods 2007, 320:155.
23. Nitta N., Aoki Y., Isogawa Y., Tsuchiya T., Kanegasaki S. Image analysis of mast cell degranulation in a concentration gradient of stimuli formed in the channel between a glass plate and a silicon substrate. Eur. J. Cell Biol. 2009, 88:541.
24. Paclet M.H., Davis C., Kotsonis P., Godovac-Zimmermann J., Segal A.W., Dekker L.V. N-Formyl peptide receptor subtypes in human neutrophils activate l-plastin phosphorylation through different signal transduction intermediates. Biochem. J. 2004, 377:469.
25. Roberts A.W., Kim C., Zhen L., Lowe J.B., Kapur R., Petryniak B., Spaetti A., Pollock J.D., Borneo J.B., Bradford G.B., Atkinson S.J., Dinauer M.C., Williams D.A. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 1999, 10:183.
26. Shin H.S., Snyderman R., Friedman E., Mellors A., Mayer M.M. Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science 1968, 162:361.
27. Showell H.J., Freer R.J., Zigmond S.H., Schiffmann E., Aswanikumar S., Corcoran B., Becker E.L. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J. Exp. Med. 1976, 143:1154.
28. Simarro M., Giannattasio G., De la Fuente M.A., Benarafa C., Subramanian K.K., Ishizawar R., Balestrieri B., Andersson E.M., Luo H.R., Orduña A., Boyce J., Anderson P. Fas-activated serine/threonine phosphoprotein promotes immune-mediated pulmonary inflammation. J. Immunol. 2010, 184:5325.
29. Stillie R., Farooq S.M., Gordon J.R., Stadnyk A.W. The functional significance behind expressing two IL-8 receptor types on PMN. J. Leukoc. Biol. 2009, 86:529.
30. Takamatsu H., Takegahara N., Nakagawa Y., Tomura M., Taniguchi M., Friedel R.H., Rayburn H., Tessier-Lavigne M., Yoshida Y., Okuno T., Mizui M., Kang S., Nojima S., Tsujimura T., Nakatsuji Y., Katayama I., Toyofuku T., Kikutani H., Kumanogoh A. Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nat. Immunol. 2010, 11:594.
31. Terashima Y., Onai N., Murai M., Enomoto M., Poonpiriya V., Hamada T., Motomura K., Suwa M., Ezaki T., Haga T., Kanegasaki S., Matsushima K. Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis. Nat. Immunol. 2005, 6:827.
32. Vercellotti G.M., Yin H.Q., Gustafson K.S., Nelson R.D., Jacob H.S. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 1988, 71:1100.
33. Ward P.A., Newman L.J. A neutrophil chemotactic factor from human C'5. J. Immunol. 1969, 102:93.
34. Ward P.A., Lepow I.H., Newman L.J. Bacterial factors chemotactic for polymorphonuclear leukocytes. Am. J. Pathol. 1968, 52:725.
35. Yamauchi A., Marchal C.C., Molitoris J., Pech N., Knaus U., Towe J., Atkinson S.J., Dinauer M.C. Rac GTPase isoform-specific regulation of NADPH oxidase and chemotaxis in murine neutrophils in vivo - role of the C-terminal polybasic domain. J. Biol. Chem. 2005, 280:953.
36. Ye R.D., Boulay F., Wang J.M., Dahlgren C., Gerard C., Parmentier M., Serhan C.N., Murphy P.M. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 2009, 61:119.
37. Zicha D., Dunn G.A., Brown A.F. A new direct-viewing chemotaxis chamber. J. Cell Sci. 1991, 99(Pt 4):769.
38. Zigmond S.H. Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J. Cell Biol. 1977, 75:606.